Pilot study of modified LMB‐based therapy for children with ataxia–telangiectasia and advanced stage high grade mature B‐cell malignancies

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|61|2|360-362

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.61, Iss.2, 2014-02, pp. : 360-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low‐grade B‐cell lymphomas

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 814-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 824-834

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increasing complexity of high‐grade B‐cell lymphomas

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1611-1613

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival Trends in Very Old Adults with Advanced Diffuse Large B‐Cell Lymphoma—A Population‐Based Study

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 3, 2015-03 ,pp. : 605-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1294-1296

John Wiley & Sons Inc

Access to resources Recommend Favorite